Research: Psilocybin for Depression & Anxiety in Parkinson's Disease

San Francisco CA

Description

The University of California, San Francisco BAND Lab is seeking adults (age 40 - 75) who have been diagnosed with Parkinson’s Disease and experience depression or anxiety. The purpose of this study is to understand whether people with Parkinson’s Disease and depression and/or anxiety have improvement in their symptoms after psilocybin therapy. Participation in the study will take approximately 55 hours across 14 visits, over the course of 20 weeks. For more information: Contact us by email / Respond to this post This study is administered by UCSF's BAND Lab, in the Department of Psychiatry and Behavioral Sciences. The principal investigator is Dr. Joshua Woolley MD/PhD, you can contact his lab by email by responding to this post.